4//SEC Filing
Galeota James JR 4
Accession 0001005201-20-000023
CIK 0001005201other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 7:32 PM ET
Size
10.6 KB
Accession
0001005201-20-000023
Insider Transaction Report
Form 4
Galeota James JR
Director
Transactions
- Exercise/Conversion
Common Stock
2020-03-30+12,492→ 12,492 total - Exercise/Conversion
Restricted Stock Units
2020-03-30−12,492→ 24,983 totalExercise: $0.00Exp: 2022-03-30→ Common Stock (12,492 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock.
- [F2]One-third of these restricted stock units are scheduled to vest on each of March 30, 2020, 2021 and 2022, assuming continued service through the applicable vesting date.
- [F3]The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Issuer
Assertio Therapeutics, Inc
CIK 0001005201
Entity typeother
Related Parties
1- filerCIK 0001721236
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 7:32 PM ET
- Size
- 10.6 KB